等待开盘 05-19 09:30:00 美东时间
+0.150
+0.93%
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
Wells Fargo analyst Michael Blum maintains Genesis Energy (NYSE:GEL) with a Overweight and lowers the price target from $19 to $18.
05-12 21:08
Companies Reporting Before The Bell • Ambev (NYSE:ABEV) is estimated to report ...
02-12 19:11
Genesis Energy (NYSE:GEL) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.13 by 138.46 percent. This is a 84.38 percent increase over losses of $(0.32) per share from the
2025-10-30 18:03
Genesis Energy (GEL) is scheduled to announce Q3 earnings results on Thursday, October 30th, before market open. The consensus EPS Estimate is $0.13. More on Genesis Energy Why I Recently Bought Energ...
2025-10-29 21:40
Gelion PLC ( ($GB:GELN) ) has shared an announcement. Gelion PLC has announced ...
2025-10-16 23:38
The latest update is out from Graphano Energy Ltd. ( ($TSE:GEL) ). Graphano Ene...
2025-10-15 00:13
Genesis Energy (NYSE:GEL) declares $0.165/share quarterly dividend, in line with previous. Forward yield 4.17% Payable Nov. 14; for shareholders of record Oct. 31; ex-div Oct. 31. Genesis will announc...
2025-10-08 18:11
An update from Graphano Energy Ltd. ( ($TSE:GEL) ) is now available. Graphano E...
2025-09-17 00:40
Wells Fargo analyst Michael Blum maintains Genesis Energy (NYSE:GEL) with a Overweight and raises the price target from $18 to $19.
2025-08-01 21:56